1Senent L,Jarque I,Martin G,et al.P-glycoprotein expression and prognostic value in acute myeloid leukemia[J].Haematologica,1998,83(1):783-787.
2Nooter K,Sonneveld P.Clinical relevance of P-glycoprotein expression in haemotological malignancies[J].Leuk Res,1994,18(4):233-243.
3Campos L,Rouault J,Sabido O,et al.High expression of bcl-2 protein in acute myeloid leukemia cell is associated with poor response to chemotherapy[J].Blood,1993,81(11):3 091-3 096.
4Sato H,Gottesman MM,Goldstein LJ,et al.Expression of the multidrug resistance gene in myeloid leukemias[J].Leuk Res,1990,14(1):11-21.
5Carter A,Dann EJ,Katz T,et al.Cells from chronic myelogenous leukemia patients at presentation exhibit multidrug resistance not mediated by either MDR-1 or MRP-1[J].Br J Haematol,2001,114(3):581-590.
6Ravandi F,Kantarjian HM,Talpaz M,et al.Expression of apoptosis proteins in chronic myelogenous leukemia:associations and significance[J].Cancer,2001,91(11):1 964-1 972.
7Delia D,Aiello A,Soligo D,et al.Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells[J].Blood,1992,79(5):1 291-1 298.
